Global ETD Search

Search theses and dissertations gathered from participating repositories worldwide. Every result links back to the library that holds it. No account is needed.

Results

Showing 1 to 20 of 1840 for “"Drug development"”.

  1. Governance of Drug Development Alliances

    … (hereafter, biotechs or biotech firms) consider drug development alliances with incumbent pharmaceutical firms (hereafter, pharmas or pharma firms) as a means to access complementary commercialization capabilities, enhance their managerial skillset through close interactions, and maintain …

    south-carolina Repository record for Governance of Drug Development Alliances (opens in a new tab)

  2. Managing Incentives in Drug Development

    … commercial incentives are too weak to support drug development, while for advanced and rare-disease treatments, regulators must make approval decisions under severe uncertainty and limited benchmarks. This dissertation adopts a mechanism design framework to analyze these distinct but related …

    duke Repository record for Managing Incentives in Drug Development (opens in a new tab)

  3. Drug development against kinetoplastid parasites

    … many problems are associated with it, including drug toxicity, resistance, lack of guaranteed supply, and high treatment cost. Therefore, there is an urgent need for new treatment approaches. Here, we aim to examine the in vitro efficacy of curcumin and phosphonium compounds against these …

    glasgow Download PDF for Drug development against kinetoplastid parasites (opens in a new tab)

  4. Process hazard review for drug development

    The development of drugs has become increasingly complex, requiring the use of a wide variety of pharmaceutical actives and isolated intermediates, a majority of which are not always completely characterized with respect to their hazard potential. This can present a source of potential exposure to …

    njit Repository record for Process hazard review for drug development (opens in a new tab)

  5. Essays on Drug Development and Marketing

    … consists of three chapters relating to drug development and marketing strategies. Chapter 1 studies strategic direct-to-consumer and direct-to-physician advertising in the pharmaceutical industry. Chapter 2 examines the strategic interaction between government agencies in funding support …

    duke Repository record for Essays on Drug Development and Marketing (opens in a new tab)

  6. Automated experiment design for drug development

    Testing drugs in discovery is time consuming and expensive. An idea is then to eliminate unpromising compounds from the testing phase by using online learning methods to predict properties of yet to be tested compounds and determining which drugs to test. This is done by comparing substructures in …

    chalmers Repository record for Automated experiment design for drug development (opens in a new tab)

  7. Therapeutic Vaccine and Drug Development for Gynecologic Cancers

    … thereby limiting its utility for pre-clinical development of vaccines. Here, we establish persistent MmuPV1 papillomas in outbred and immune competent SKH1-Elite mice (Crl:SKH1-Hrhr) as a promising model to study potential immunotherapies for PV-related disease and the relationship between …

    jhu Repository record for Therapeutic Vaccine and Drug Development for Gynecologic Cancers (opens in a new tab)

  8. The Genetics of Cancer in Pharmacological Drug Development

    The field of cancer therapeutic development has been dominated by two research and discovery paradigms, the cytotoxicity-based or phenotype driven strategy and the target-based rational approach. This thesis describes the standardization of novel assays used in both approaches and the discoveries …

    temple Repository record for The Genetics of Cancer in Pharmacological Drug Development (opens in a new tab)

  9. Targeting schistosome cholinesterases for vaccine and drug development

    … has been successfully targeted by anthelmintic drugs but the use of many of these has discontinued because of toxic side effects and so there is a need to better understand key neuronal processes at a molecular level to develop safer and more effective intervention strategies that target this …

    jamescook Download PDF for Targeting schistosome cholinesterases for vaccine and drug development (opens in a new tab)

  10. A Three Dimensional Scaffold for Anticancer Drug Development

    Attrition rates for anticancer drugs are much higher than any other therapeutic area. Only 5%#37; of the agents that demonstrate anticancer activity in the preclinical stages of development demonstrate clinical efficacy in phase III trials. This high attrition rate becomes alarming when we consider …

    usf Repository record for A Three Dimensional Scaffold for Anticancer Drug Development (opens in a new tab)

  11. Unsupervised Learning of Molecular Representations for Drug Development

    … to the field of chemistry and pharmaceutical drug development in particular. Recently, there has been a surge of interest in using machine learning to predict molecular properties such as the binding affinity to protein targets of interest or to generate molecular structures with desirable …

    fu-berlin Repository record for Unsupervised Learning of Molecular Representations for Drug Development (opens in a new tab)

  12. Genetically engineered mouse models in preclinical drug development

    … facilitate the study of mechanisms underpinning drug resistance. Using the BLG--HER2KI-PTEN+/- model, we demonstrated that Src plays an important role in the early stages of tumour development. Chemopreventative treatment with dasatinib delayed tumour inititation (p= 0.046, Wilcoxon signed rank …

    edinburgh Repository record for Genetically engineered mouse models in preclinical drug development (opens in a new tab)

  13. APPLICATION OF MACHINE LEARNING APPROACHES TO EMPOWER DRUG DEVELOPMENT

    … antimicrobials, are in urgent need. However, the drug development process is long, complex, and risky with no guarantee of success. Also, the improvements in techniques applied in genomics, proteomics, computational biology, and clinical trials significantly increase the data complexity and …

    utk-theses Repository record for APPLICATION OF MACHINE LEARNING APPROACHES TO EMPOWER DRUG DEVELOPMENT (opens in a new tab)

  14. Application of Pharmacometric Methods to Improve Pediatric Drug Development

    … that is rapidly changing the landscape of drug development, and particularly so for the pediatric population. The motivation behind the research underlying this dissertation is to contribute towards the improvement of pediatric drug development by the astute application of pharmacometric …

    vcu Repository record for Application of Pharmacometric Methods to Improve Pediatric Drug Development (opens in a new tab)

  15. Protein and Ligand Dynamics in Drug Development and Resistance

    … therapeutics. In this work, we describe the development and implementation of novel techniques to study dynamics in proteins and protein-bound ligands, and discuss our investigation of the crucial role of dynamics in two disease-relevant systems.</p><p>First, we have expanded the utility of …

    duke Repository record for Protein and Ligand Dynamics in Drug Development and Resistance (opens in a new tab)

  16. Functional Connectivity and Machine Learning for Psychiatric Drug Development

    The human brain is a complex biological network consisting of spatially separated but functionally integrated regions. Study of functional connectivity gained immense popularity in recent years providing new insight into the mechanisms underlying complex functions and the fundamental organisation …

    kings Repository record for Functional Connectivity and Machine Learning for Psychiatric Drug Development (opens in a new tab) Download PDF for Functional Connectivity and Machine Learning for Psychiatric Drug Development (opens in a new tab)

  17. The persistence and burden of failing drug development paradigms

    Background: Failures in cancer drug development impose heavy burdens on patients, researchers, industry, and funders. Burdens in targeted drug development could be mitigated if investigators efficiently integrated not only trial outcomes, but also evidence for underlying pathophysiological …

    fu-berlin Repository record for The persistence and burden of failing drug development paradigms (opens in a new tab)

Page 1 of 92